º£½ÇÉçÇø

  1. º£½ÇÉçÇø
  2. Healthcare
  3. Clinical Trials
  4. Results

Search for Clinical Trials

BN013: Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain (H-56702)
NRG-BN013: Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain MetastasesThis phase…
  • Cancer - All
  • Cancer - Brain
  • Cancer - Breast
  • Cancer - Colon/Rectal
  • Cancer - Kidney/Renal
  • Cancer - Lung
  • Cancer - Metastatic
View Clinical Trial
S2312: Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer (H-56696)
S2312: A Phase III Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC),…
  • Cancer - All
  • Cancer - Prostate
  • Urology
View Clinical Trial
MODERN (A032103): Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment (H-56225)
MODERN (A032103): An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcerThis phase II/III trial…
  • Cancer - All
  • Cancer - Bladder
  • Urology
View Clinical Trial
OnPrime, GOG-3076: Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (H-55801)
A Randomized Phase 3 Study Assessing the Efficacy and Safety of Olvi-Vec Followed by Platinum-doublet Chemotherapy and Bevacizumab Compared With…
  • Cancer - All
  • Obstetrics and Gynecology
View Clinical Trial
PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer (H-56035)
S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-…
  • Cancer - All
  • Cancer - Gastric/Stomach
  • Digestive System
View Clinical Trial
ASCENT-GYN-01: Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer (H-56008)
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who…
  • Cancer - All
  • Cancer - Cervical
  • Obstetrics and Gynecology
View Clinical Trial
HN009: Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer (H-53399)
NRG-HN009:  Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at…
  • Cancer - All
  • Cancer - Head/Neck
  • Head and Neck
View Clinical Trial
CIRCULATE-US: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (H-52559)
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor…
  • Cancer - All
  • Cancer - Colon/Rectal
View Clinical Trial
BN011: Testing the Addition of the Drug Lomustine to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma (H-52827)
NRG-BN011:  A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients With Methylated MGMT…
  • Cancer - All
  • Cancer - Brain
  • Neurology
View Clinical Trial
MajesTEC-9: Teclistamab Monotherapy vs Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (H-53936)
MajesTEC-9: A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib,…
  • Cancer - All
  • Cancer - Hematology
  • Cancer - Myeloma
View Clinical Trial
Back to topback-to-top